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1. Introduction  
Nigella sativa (N. sativa) is an annual flowering herb of the Ranunculaceae family and genus 
Nigella which has 18 species, native to South and Southwest Asia, Southern Europe, and North 
Africa. Since 1880, numerous studies had been conducte  on its bioactivities including 
thrombolytic and fibrinolytic properties (Awad and Binder, 2005; Asgary et al., 2012; Lebda et al., 
2012). Since time immemorial, N. sativa (L.) seeds had been used traditionally in Unani, Tibb, 
Ayurveda, Siddha, and Arabic medicines (Ahmad et al., 2013). Primarily, it is composed of fixed 
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 The Water-Soluble Extract (WSE) is a crude bioactive phytoconstituent 
of Nigella sativa (L.) seeds discovered recently. The current findings 
report about the thrombolytic and cytotoxic effects of WSE using 
human blood clot lysis and brine shrimp lethality (BSL) bioassay. The 
thrombolytic effect of WSE (1,666.67 µg/mL) was determined via the 
clot and lysate weight measurements compared to streptokinase (STK) 
of 30,000 IU/mL and normal saline (NS) while the cytotoxicity of WSE 
(44.14-2,000 µg/mL) against vincristine sulfate (VCS;3.125-100 
µg/mL). WSE has shown extremely statistically signif cant (p<0.0001) 
clot lysis (90.00%) compared to NS (3.76%) whilst it was also 
significantly different (p<0.0063) to STK (72.41%) exhibiting LC50 of 
1,795.90 µg/mL vs. VCS (39.25 µg/mL) in a dose-dependent manner. 
The current results suggested WSE has a potent thrombolytic effect with 
mild dose-dependent cytotoxicity towards brine shrimp nauplii (Artemia 
salina). It also suggested WSE might have enzymatic roles n thrombin, 
fibrin, and plasmin of blood. This pharmacological action of WSE is 
might be due to its antioxidant property, short-chain fatty acids and/or 
amino acids. Further studies are highly recommended on the enzymatic 
role(s) and bioactive phytoconstituents of WSE. 
 
This is an open access article under the CC–BY-SA license. 
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oil (≤38%), essential oil (≤1.5%), dietary protein (≤26.7%), fat (≤28.5%), and carbohydrate 
(≤40%). In its essential oil, thymoquinone (TQ), the so-called most bioactive compound was 
reportedly found up to 48% whilst other bioactives include t-anethole (4%), 4-terpineol (7%), 
sesquiterpene longifolene (8%), carvacrol (12%), p-cymene (15%), thymol, dihydrothymoquinone 
(DTQ) and thymohydroquinone (THQ). In fixed oil, it was reported to contain mainly linoleic acid 
(65%), oleic acid (24%), palmitic acid (20%), dihomlinoleic acid (10%) and eicosadienoic acid 
(3%) and many fatty acids including sterol esters and glycosides (Ahmad et al., 2013; Al-Jassir, 
1992; Houghton et al., 1995; Cheikh-Rouhou et al., 2007; Gholamnezhad et al., 2016).  
The WSE was found to be highly polar by nature with solubility in both 5% NaOH and HCl 
solutions which might be an indication of a wide range of solubility or therapeutic index with 
active δ+ and δ− sites. It has also shown more than two-fold stronger antioxidant capacity than its 
fixed oil (Babar et al., 2019a). 
Thrombolytic or fibrinolytic drugs are being used to treat coronary artery disease, deep vein 
thrombosis, myocardial infarction, strokes, and pulmonary embolism, etc. Most of the thrombolytic 
drugs target the fibrin, one of the main constituens of a blood clot to lyse the clot (Babar et al., 
2019a; Dewan and Das, 2013). Fibrin, thrombin, and plasmin play vital roles individually and/or 
collectively in blood coagulation, thrombosis, and hemostasis while various enzymes, cofactors, 
and receptors, such as serine protease, cofactor V and VIII and protease-activated receptors (PARs) 
are also involved respectively (Tanaka et al., 2009; Ali et al., 2014; Chapin and Hajjar, 2015). 
Cytotoxicity of thymoquinone, essential oil, and different fractions of N. sativa (L.) seeds has been 
studied extensively but there was no such report about WSE. A recent study conducted on the 
cytotoxicity of various fractions (i.e., petroleum ether, ether, methanol, chloroform, and water) and 
essential oil of N. sativa on brine shrimp through the paper disc and solution methods found 
petroleum ether and chloroform to be the most cytotoxic with LC50 of 7 and 21 µg/mL 
respectively whilst the aqueous fraction has shown insignificant cytotoxicity for the above two 
methods (Mahmoudvand et al., 2017). Therefore, the current study was aimed to investigate the 
thrombolytic (i.e., % clot lysis) and cytotoxic (i.e., % mortality) effects of WSE using human blood 
clot lysis and brine shrimp lethality (BSL) assays re pectively.  
2. Materials and methods 
2.1 Extraction and yield of WSE 
The detailed process of extraction and yield of WSE has been discussed in our earlier report (Babar 
et al., 2019a). This is the preliminary study of our recent study (Babar et al., 2019b) on WSE, 
which was preserved at 3 ±1°C in a Falcon® tube (50 mL) wrapped with aluminium foil. It was 
noted that 1 µL contains ≈0.88 mg (w/v) of WSE. A significant amount (≈15 g) of WSE was sent 
safely to the Department of Pharmacy, International Islamic University Chittagong (IIUC), 
Bangladesh from Kuala Lumpur.  Upon arrival at the mentioned institution, the sample was kept at 
4 °C until use. 
 
2.2 Ethical consideration 
As the current study is a part and preliminary experim nt of our recent study (Babar et al., 2019b), 
thus, this study protocol was also approved by the Institutional Ethics Committee (IEC) of the 
Department of Pharmacy, IIUC under the same referenc  (Pharm/PND/138/13#2019). 
 
2.3 Guidelines  
The current study has strictly followed and maintaied the recommendations (v 1.1, June 2018) of 
the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) on the best 
practices of venous blood sampling (Simundic et al., 2018). For hatching the brine shrimp nauplii, 
the notes and instructions of ‘Ocean Nutrition Americas’, was followed. 
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 2.4 Materials  
The stabilized pure streptokinase (STK® Inj.; 1.5 million IU) vial in powder form produced by 
Incepta Pharmaceuticals Ltd., Sodium Chloride BP 0.9% w/v and Dextrose 5% USP w/v solution 
(Solodex™ IV Infusion) manufactured by Square Pharmaceuticals Ltd., Bangladesh, and two vials 
of vincristine sulfate (Criston 2, 2mg/2mL; Beacon Pharmaceutical Ltd., Bangladesh) were bought 
from a local pharmacy shop in Chittagong. The 50 g of brine shrimp of ‘S.K Artemia Cysts’ brand 
imported from Thailand was purchased from a local supplier in Cox’s Bazar. The portable aeration 
pump (Brand: Amplab Bangladesh) with a single air-flow was purchased from the online shopping 
site (www.daraz.com.bd). 
  
2.5 WSE stock and working solutions preparation 
A stock solution of WSE (10,000 µg/mL) was prepared by adding 125 µL of WSE into 11 mL of 
normal saline (NS) water for both  thrombolytic and cytotoxic studies, and 12 random 5x 
concentrations of aliquots (i.e., 5x/mL w/v; 3 mL/aliquot) for 44.14, 66.21, 88.28, 132.42, 176.56, 
264.84,  353.13, 529.69, 706.25, 1059.38, 1,412.50 and 2,000.00 µg/mL of WSE were prepared by 
adding the corresponding volume of 66.21 µL, 99.32 µL, 132.42 µL, 198.63 µL, 264.84 µL, 397.26 
µL, 529.70 µL, 794.54 µL, 1,059.38 µL, 1,589.07 µL,  2,118.75 µL and 3,000 µL of WSE from the 
stock respectively into ≤3.00 mL (i.e., 2,933.79 to 0.00 µL) of the artificial seawater (3.8% NaCl/L 
w/v, pH 8.0).  For thrombolytic assay, 166.67 µL of stock was directly added into the tubes 
(n=6×3) containing 0.5 mL blood and filled up to 1.0 mL using NS (≈333.33). 
 
2.6 Preparation of streptokinase (STK) stock  
The powder form of STK vial (1.5 million IU) was reconstituted and diluted by adding 5.0 mL of 
Solodex™ IV Infusion at the sidewall of the vial just immediately before the use. It was tilted, 
rolled gently until fully reconstituted. The stock oncentration was 300,000 IU/mL. 
 
2.7 Preparation of vincristine sulfate (VCF) solution 
The two VCF vials (Criston 2; 1mg/mL; 2mL/vial) were further diluted by adding 2 mL of normal 
saline (NS;0.9% NaCl)  to each vial to get a 4 mL vial of 500 µg/mL of two stocks so that six 
consecutive concentrations (500-15.625 µg/mL) of aliquots (4 mL/tube) could be prepared and the 
stocks also left with 3 mL/vial after dilution. The details of the dilution process have been 
described graphically in Fig. 4. 
 
2.8 Blood samples collection 
After having the prior consent, the whole fasting blood (WFB) sample (5.0 mL/subject) of adult 
male (23-26 years old) was aseptically withdrawn in the morning (i.e., 8:00-8:15 am) after at least 
12 hr of fasting using a 5.0 mL syringe with a needl  via venipuncture method (Simundic et al., 
2018). 
 
2.9 Brine shrimp nauplii hatching & collection 
The brine shrimp nauplii were hatched in 1 L of artificial seawater (i.e., 3.8% NaCl/L w/v) 
prepared by adding 38 gram of unrefined sea salt into 1 L of distilled water in a  beaker to which 
2.5 g of ‘S.K Artemia Cysts’ was added.,  A 60 W bulb above the beaker (8″), single air-flow 
aeration pump and glass thermometer was fitted to maintain the light, the temperature at 28 °C and 
oxygen supply while the pH was 8. The brine shrimp nauplii hatched after 24 hr were immediate 
transfer to a freshly prepared media before drug exposure. 
  
4.10 Thrombolytic assay  
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The in-vitro thrombolytic activity of WSE was perfomed using the methods described by (Prasad 
et al., 2006) with some minor modifications followed by the EFLM recommendations (Simundic et 
al., 2018). 0.5 mL of WFB  sample from each subject in a triplicate manner for three different tests  
(i.e., NS, STK, and WSE) was transferred into the corresponding pre-weighed (0.80±0.01 g/empty 
tube) sterile collection tubes (1.5 mL) and were again weighed before incubation for 45 minutes at 
37 °C to allow clot formation. After clot formation, the serum was gently aspirated and the weight 
of each of the 54 tubes (n=6×3×3) containing blood cl t was taken at room temperature (24 ±2 °C) 
before NS, STK and WSE was added. Subsequently, 166.7 μL of WSE from the stock was added 
into 18 respective tubes (n=6×3). Similarly, 100 μL of STK (300,000 IU/mL) and 500 µL of NS 
(0.9% NaCl) were added before incubation at 37 °C for 90 minutes and observed closely for clot 
lysis. After incubation, the lysate (i.e., upper phase) was discarded carefully and the weight of the 
tube containing the blood clot was recorded. The diff rence in clot weight before and after lysate 
formation was expressed as the percent of clot lysis (Fig. 1) using the following equation (1).  
Clot lysis 	% =  
	  
	    
× 100 
                                                     Eq. 1 
 
The weight of blood clot was calculated using the equation (2) as followed; 
Weight of clot (g)=Weight of tube containing blood clot – Weight of empty tube   Eq. 2 
 
2.11 Brine shrimp lethality (BSL) bioassay 
The BSL bioassay was carried based on the methods of (Meyer et al., 1982; Houghton et al., 1995; 
Cheikh-Rouhou et al., 2007; Gholamnezhad et al., 2016), with few modifications. 10 healthy-
looking immobilized nauplii (Babar et al., 2019a) along with 1 mL of media were transferred into 
each of the 57 glass test tubes labeled and prefilled with 1 mL of fresh media in advance. Then, 1 
mL of WSE from each of the 12 aliquots, 1 mL of VCS from each of the 6 aliquots were added in 
triplicate manner. The volume was filled up to 5 mL using the seawater. The negative control 
contained only 5 mL seawater. The final log concentrations of VCS were from 100 to 3.125 µg/mL 
(Fig. 4). Finally, all the treated and control groups (5 mL/test/tube) were incubated at room 
temperature (26 ±1 °C) for 24 hr (12/12; light/dark cycle), the survived and died nauplii population 
was screened and counted using a handheld magnifying glass. The median lethal concentration 
(LC50) of the test samples was calculated from the linear regression equation of the scatter graph 
whilst the % of mortality was calculated by using the following equation (3):  
% Mortality   =  
	" #. #%& ''/)#
	" #. #%& %'/)# 
 × 100                            Eq. 3 
 
2.12 Data analysis 
The results are expressed as mean ± SD and compared between treated and control groups, 
employing a Student’s unpaired two-tailed t-test using GraphPad Prism 8 online. A p-value of less 
than 0.05 was considered statistically significant.  
3. Results and Discussion 
3.1. Thrombolytic effect of WSE 
The exposure of a single, randomly selected WSE (1666.67 µg/mL) to healthy adult male human 
blood (0.5 mL×3) against streptokinase (STK:72.41 ±0.01%) of 30,000 IU/mL and normal saline 
(NS:3.76 ±0.49%) has shown statistically significant (p <0.0063 & p <0.0001) % clot lysis by WSE 
(90.00 ±0.02%) as shown in Fig. 1.  
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Fig 1. The mean % clot lysis ± SD of WSE (90 ±0.02%) after 24 hr of exposure vs. normal saline, NS (3.76 
±0.49%) and streptokinase, STK (72.41 ±0.01%). *Indicates the % clot lysis of WSE to be extremely 
statistically significant (p<0.0001) vs. NS and (p<0.0063) vs. STK. 
 
3.2. Cytotoxic effect of WSE 
The exposure of twelve randomly selected concentrations of WSE (44.14, 66.21, 88.28, 132.42, 
176.56, 264.84, 353.13, 529.69, 706.25, 1059.38, 1,412.50 and 2,000.00 µg/mL) to brine shrimp 
nauplii for 24 hours against the vincristine sulfate, VCS (LC50=39.25 µg/mL) in artificial seawater 
(3.8% NaCl/L) has exhibited very mild cytotoxicity bearing LC50=1795.90 µg/mL as shown in Fig. 
2. The current result of WSE is about 46 times lesspotent than VCS, Fig.3. It is also found that the 
current LC50 of VCS is more than 8 times potent than a previous report (LC50=0.33 ±0.055 
mg/mL) made by (Rahmatullah et al., 2010). 
  
Fig 2. The mean % mortality of brine shrimp nauplii (n=10×2 3) caused by WSE of 44.14-2,000 µg/mL in 
triplicate manner, after 24 hr of exposure at room te perature showing LC50=1795.90 µg/mL. 
n = 6×3 
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Fig 3. The mean % mortality of brine shrimp nauplii (n=10×6×3) caused by the VCS of 100-3.125 µg/mL in 
triplicate manner after 24 hr of exposure at room te perature having LC50=39.25 µg/mL. 
 
   
Fig 4. The preparation of six vincrestine sulfate (VCS) aliquots (500-15.625 µg/mL) (4 mL/aliquot) via serial 
dilution using normal saline (NS), and treatment (5 mL) concentrations (100-3.125 µg/mL) in triplicate 
manner. 
4. Conclusion 
It could be concluded that WSE has a potent thrombolytic effect with mild dose-dependent 
cytotoxicity towards brine shrimp nauplii (Artemia salina). It is also proposed that WSE might 
have a vital enzymatic role on thrombin, fibrin, and plasmin of blood which may involve serine 
proteases and protease-activated receptors (PARs). Thi  pharmacological action of WSE is might 
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be due to its antioxidant property, short-chain fatty cids, and/or amino acids. Further studies are 
highly recommended on the enzymatic role(s) and bioact ve phytoconstituents of WSE. 
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